Erythropoietin use in the critically ill: current evidence.

Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10673

Full metadata record

DC Field	Value	Language
dc.contributor.author	Warrillow, Stephen J	en
dc.date.accessioned	2015-05-16T00:12:07Z
dc.date.available	2015-05-16T00:12:07Z
dc.date.issued	2008-09-01	en
dc.identifier.citation	Critical Care and Resuscitation; 10(3): 257-60	en
dc.identifier.govdoc	18798726	en
dc.identifier.other	PUBMED	en
dc.identifier.uri	https://ahro.austin.org.au/austinjspui/handle/1/10673	en
dc.language.iso	en	en
dc.subject.other	Anemia.drug therapy	en
dc.subject.other	Critical Illness	en
dc.subject.other	Erythropoietin.adverse effects.therapeutic use	en
dc.subject.other	Humans	en
dc.subject.other	Recombinant Proteins	en
dc.subject.other	Treatment Outcome	en
dc.title	Erythropoietin use in the critically ill: current evidence.	en
dc.type	Journal Article	en
dc.identifier.journaltitle	Critical Care and Resuscitation	en
dc.identifier.affiliation	Department of Intensive Care, Austin Health, Heidelberg, Victoria, Australia, Australia	en
dc.description.pages	257-60	en
dc.relation.url	https://pubmed.ncbi.nlm.nih.gov/18798726	en
dc.type.austin	Journal Article	en
local.name.researcher	Warrillow, Stephen J
item.openairetype	Journal Article	-
item.cerifentitytype	Publications	-
item.grantfulltext	none	-
item.fulltext	No Fulltext	-
item.openairecristype	http://purl.org/coar/resource_type/c_18cf	-
item.languageiso639-1	en	-
crisitem.author.dept	Intensive Care	-
Appears in Collections:	Journal articles

32

checked on Nov 27, 2024

Check